| Patents for C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media (9,992) |
|---|
| 09/16/2004 | WO2004013291A3 Primers and primer sets for use in methods to detect the presence of acidovorax avenae subsp. citrulli |
| 09/16/2004 | US20040180445 Methods and compositions for purification of nucleic acid from a host cell |
| 09/16/2004 | US20040180364 Methods for analyzing global regulation of coding and non-coding RNA transcripts involving low molecular weight RNAs |
| 09/16/2004 | US20040180328 Methods for rapid detection and identification of bioagents for environmental and product testing |
| 09/16/2004 | US20040178390 Organic species that facilitate charge transfer to or from nanostructures |
| 09/16/2004 | CA2517974A1 Use of antisense oligonucleotides or sirna to suppress expression of eif-5a1 |
| 09/16/2004 | CA2517857A1 Methods for preventing gluconoylation of proteins |
| 09/16/2004 | CA2517856A1 Removal of plastid sequences by transiently expressed site-specific recombinases |
| 09/16/2004 | CA2517287A1 Regulation of t cells by lag-3 (cd223) |
| 09/16/2004 | CA2517101A1 A modified oligonucleotide for inhibition of growth hormone receptor expression |
| 09/16/2004 | CA2517097A1 Identification of antigen epitopes |
| 09/16/2004 | CA2516677A1 Intracellular delivery of small molecules proteins and nucleic acids |
| 09/16/2004 | CA2516519A1 Animal model for the fast identification of pharmaceutical active compounds in vivo |
| 09/15/2004 | EP1456362A2 Method for the generation of proteins with new enzymatic function |
| 09/10/2004 | WO2004076651A2 Generation of dendritic cells from monocytic dendritic precursor cells with gm-csf in the absence of additional cytokines |
| 09/10/2004 | WO2004076650A2 Angiopoietin and fragments, mutants, and analogs thereof and uses of the same |
| 09/10/2004 | WO2004076649A2 Methods, systems and apparatus for identifying genetic differences in disease and drug response |
| 09/10/2004 | WO2004076648A2 Clinically relevant animal model of human breast cancer and vegf involement in desmoplastic response. |
| 09/10/2004 | WO2004076647A2 Use of steady-state oxygen gradients to modulate animal cell functions |
| 09/10/2004 | WO2004076645A2 Compositions and methods for cytomegalovirus treatment |
| 09/10/2004 | WO2004076644A2 A composition for delivering an agent to a target cell and uses thereof |
| 09/10/2004 | WO2004076643A2 CIRCULATING TUMOR CELLS (CTC’s): EARLY ASSESSMENT OF TIME TO PROGRESSION SURVIVAL AND RESPONSE TO THERAPY IN METASTATIC CANCER PATIENTS |
| 09/10/2004 | WO2004076642A2 Method for modulating epithelial stem cell lineage |
| 09/10/2004 | WO2004076640A2 Small-molecule inhibitors of angiogenin and rnases and in vivo and in vitro methods of using same |
| 09/10/2004 | WO2004076637A2 Cell-polymer fiber compositions and use thereof |
| 09/10/2004 | WO2004076636A2 A novel human g-protein coupled receptor, hgprbmy23, expressed highly in kidney |
| 09/10/2004 | WO2004076635A2 Therapeutic applications of thrombomodulin gene via viral and non-viral vectors |
| 09/10/2004 | WO2004076634A2 Cell membrane translocation of regulated snare inhibitors , compositions therefor, and methods for treatment of disease |
| 09/10/2004 | WO2004076633A2 Hypoxia inducible vegf plasmid for ischemic disease |
| 09/10/2004 | WO2004076632A2 Methods of screening for trpm5 modulators |
| 09/10/2004 | WO2004076631A2 Biologically active native biomatrix composition |
| 09/10/2004 | WO2004076629A2 METHODS AND CONSTRUCTS FOR EVALUATION OF RNAi TARGETS AND EFFECTOR MOLECULES |
| 09/10/2004 | WO2004076625A2 Method of identifying plant cells transformed with a gene |
| 09/10/2004 | WO2004076624A2 Compositions and methods for neural cell production and stabilization |
| 09/10/2004 | WO2004076623A2 Rna-interference for znfn3a1-gene as a method for inhibiting cancer cell growth |
| 09/10/2004 | WO2004076622A2 Regulation of gene expression by dna interference |
| 09/10/2004 | WO2004076621A2 Compositions of nucleic acids for treating and detecting influenza virus |
| 09/10/2004 | WO2004076614A2 Human nucleic acid sequences obtained from prostatic carcinomas |
| 09/10/2004 | WO2004044131A8 Cross-linked oligomeric compounds and their use in gene modulation |
| 09/10/2004 | WO2004042023A3 Stem cell libraries |
| 09/10/2004 | WO2003066801A3 Method for specific integration of t7 rna polymerase gene in the chromosome of corynebacterial and the resultant corynebacteria-t7 promoter based shuttle vector system. |
| 09/10/2004 | CA2517295A1 Generation of dendritic cells from monocytic dendritic precursor cells with gm-csf in the absence of additional cytokines |
| 09/10/2004 | CA2517235A1 Methods and constructs for evaluation of rnai targets and effector molecules |
| 09/10/2004 | CA2517082A1 Clinically relevant animal model of human breast cancer and vegf involvement in desmoplastic response |
| 09/10/2004 | CA2517074A1 Nucleic acid molecules, polypeptides, antibodies and compositions containing same useful for treating and detecting influenza virus infection |
| 09/10/2004 | CA2516795A1 Circulating tumor cells (ctc's): early assessment of time to progression,_survival and response to therapy in metastatic cancer patients |
| 09/10/2004 | CA2516727A1 Hypoxia inducible vegf plasmid for ischemic disease |
| 09/10/2004 | CA2516651A1 Methods of screening for trpm5 modulators |
| 09/10/2004 | CA2515916A1 Therapeutic applications of thrombomodulin gene via viral and non-viral vectors |
| 09/10/2004 | CA2515586A1 Regulation of gene expression by dna interference |
| 09/09/2004 | US20040175813 can be delivered separately or in combination with apoptotic inducing agents via aerosol liposome/transfection/infection methods to treat cellular proliferative diseases and disorders in humans and animals |
| 09/09/2004 | US20040175743 Using cancer marker gene expression profile in peripheral blood mononuclear cells to diagnose cell proliferative disorders and screen efficacy of antitumor agents |
| 09/09/2004 | US20040175719 Nucleotide sequences probes comprised of 20-60 bases for use as diagnostic tools and controls in genic analysis; bioassay |
| 09/09/2004 | US20040175704 Compositions and methods for polynucleotide sequence detection |
| 09/09/2004 | US20040175362 Infectivity-enhanced conditionally-replicative adenovirus and uses thereof |
| 09/09/2004 | US20040173227 Filter containing a metal phthalocyanine and a polycationic polymer |
| 09/08/2004 | EP1453382A2 Methods and compositions for correction of cardiac conduction disturbances |
| 09/02/2004 | WO2004074460A2 Nucleotide and protein sequences of coc genes and methods based thereon |
| 09/02/2004 | WO2004074456A2 Methods for selecting medications |
| 09/02/2004 | WO2004074452A2 Multiplex mapping of protein interactions |
| 09/02/2004 | WO2004074449A2 Filter containing a metal phthalocyanine and a polycationic polymer |
| 09/02/2004 | WO2004074446A2 Parkin interacting polypeptides and methods of use |
| 09/02/2004 | WO2004074445A2 Model for studying the role of genes in tumor resistance to chemotherapy |
| 09/02/2004 | WO2004074437A2 Compositions and methods for cancer immunotherapy |
| 09/02/2004 | WO2004074434A2 Methods and compositions for administering therapeutic and diagnostic agents |
| 09/02/2004 | WO2004074428A2 Treatment of metabolic disorders |
| 09/02/2004 | WO2004074427A2 Three dimensional model for protein or part of protein structure |
| 09/02/2004 | WO2004073736A1 Attenuated strains of vibrio cholerae and lyophilised vaccines containing same |
| 09/02/2004 | WO2004053076A3 Methods for rapid detection and identification of bioagents for environmental and product testing |
| 09/02/2004 | WO2004050840A3 Integration of gene expression data and non-gene data |
| 09/02/2004 | WO2004016765A3 Method for search based character optimization |
| 09/02/2004 | WO2004015079A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 09/02/2004 | US20040171108 Human excitatory amino acid transporter-2 gene promoter and uses thereof |
| 09/02/2004 | US20040171105 Using enzymatic polypeptide to inactivate inhibitor of apoptosis and activate caspase for treatment and prevention of cancer, autoimmune and neurodegenerative diseases |
| 09/02/2004 | US20040171075 Modulation of protein functionalities |
| 09/02/2004 | US20040170981 Real-time polymerase chain reaction using large target amplicons |
| 09/02/2004 | US20040170975 alternative splicing variant of tumor necrosis factor receptor (TNFR); for detection assays; solid phase synthesis; genetic engineering |
| 09/02/2004 | US20040170958 Viral drug susceptibility testing |
| 09/02/2004 | US20040170954 determining the level of potentially active biological pathogens in a biological material using quantitative polymerase chain reaction (PCR) |
| 09/02/2004 | CA2514277A1 Methods and compositions for administering therapeutic and diagnostic agents |
| 09/01/2004 | EP1451370A2 Chromosomal saturation mutagenesis |
| 09/01/2004 | EP1451365A2 Dna amplification and sequencing using dna molecules generated by random fragmentation |
| 09/01/2004 | EP1451333A2 Ul16 binding protein 4 |
| 09/01/2004 | EP1451295A2 Methods for mutating genes in cells and animals using insertional mutagenesis |
| 09/01/2004 | EP1451291A2 Methods for identifying, isolating, and controlling the growth of estrogen-responsive cells |
| 09/01/2004 | EP0610254B1 Glial derived neurotrophic factor |
| 08/26/2004 | WO2004072269A2 Bex4 nucleic acids, polypeptides, and method of using |
| 08/26/2004 | WO2004072267A2 Enzymes |
| 08/26/2004 | WO2004072266A2 Antibody affinity engineering by serial epitope-guided complementarity replacement |
| 08/26/2004 | WO2004072265A2 Methods for monitoring drug activities in vivo |
| 08/26/2004 | WO2004072263A2 Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers |
| 08/26/2004 | WO2004072262A2 Cultured cd14+ antigen presenting cells |
| 08/26/2004 | WO2004072260A2 Cell free assay systems for identifying a substance of interest |
| 08/26/2004 | WO2004072259A2 Altered fad2 and fad3 genes in brassica and the molecular marker-assisted detection thereof |
| 08/26/2004 | WO2004072257A2 Dyrks as modifiers of the apc and axin pathways and methods of use |
| 08/26/2004 | WO2004072256A2 Variants of cytochrome c and methods of diagnostics of thrombocytopenia |
| 08/26/2004 | WO2004072255A2 Methods of treating disease |
| 08/26/2004 | WO2004072253A2 Human excitatory amino acid transporter-2 gene promoter and uses thereof |
| 08/26/2004 | WO2004072252A2 Polymerase-based protocols for the introduction of deletions and insertions |
| 08/26/2004 | WO2004072247A2 Polymerase-based protocols for generating chimeric and combinatorial chimeric oligonucleotides |